Effect of Shengmai injection on cardiac function and inflammatory reaction in patients with Acute Coronary Syndrome

Chinese Journal of Integrative Medicine

Volumn 14, Issue 2, 2008, Pages 107-110

  Zhang, Ya Chen ^a   Chen, Rui Ming ^b   Lu, Bao Jing ^a   Rong, Ye Zhi ^a  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Acute coronary syndrome; C reactive protein; Cardiac function; Inflammatory reaction; Shengmai injection

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CHINESE DRUG; LOW MOLECULAR WEIGHT HEPARIN; SHENGMAI;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; HEART PALPITATION; HEART STROKE VOLUME; HUMAN; INFLAMMATION; KIDNEY FUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; SIDE EFFECT; TREATMENT OUTCOME; VENOUS BLOOD;

ACUTE CORONARY SYNDROME; C-REACTIVE PROTEIN; DRUG COMBINATIONS; DRUGS, CHINESE HERBAL; FEMALE; HEART FUNCTION TESTS; HEMODYNAMICS; HUMANS; INFLAMMATION; INJECTIONS; MALE; MIDDLE AGED; VENTRICULAR FUNCTION, LEFT;

EID: 46749119082     PISSN: 16720415     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11655-008-0107-3     Document Type: Article

References (11)

1. Biasucci LM, Liuzzo G, Grillo RL, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999;99:855-860.
2. Libbyb P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-1143.
3. Ross R. Atherosclerosis-an inflammation disease. N Engl J Med 1999 14;340:115-126.
4. Anwar A, Zahid AA, Scheidegger KJ, et al. Tumor necrosis factor-alpha regulates insulin-like growth factor binding protein-3 expression in vascular smooth muscle. Circulation 2002;105:1220-1225.
5. van der Wal AC, Becker AE, van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
6. Zhang YC, Chen RM, Zhao MH, et al. Effect of Shengmai Injection on hemodynamics in patients with dilated cardiomyopathy. Chin J Integr Tradit West Med (Chin) 2002;22(4):277-279.
7. Chen YM, Yang JX, Xu JM, et al. Effect of Sheng-mai-san Injection vs Astragalus membranaceus Injection in treating coronary heart disease with left ventricular dysfunction. Chin J New Drugs Clin Remedie (Chin) 1998;17 (3):154-156.
8. London CL, Davies MJ, Born GV, et al. Atherosclerotic plaque caps are locally weakened when macrophages density is increased. Atherosclerosis 1991;87:87-90.
9. Biasucci LM, D'Onofrio G, Liuzzo G, et al. Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia. J Am Coll Cardiol 1996;27:611-616.
10. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994;331:417-424.
11. Lu BJ, Rong YZ, Zhao MH, et al. Effect of Shengmaisan on lipid peroxidation damage in acute myocardial infarction patients. Chin J Integr Tradit West Med (Engl) 1996;2(4):249-251.